Get the Stockscreener App
3.94
4.60%
-0.19
After Hours:
3.94
Cytek Biosciences Inc stock is traded at $3.94, with a volume of 974.07K.
It is down -4.60% in the last 24 hours and down -2.23% over the past month.
Cytek Biosciences Inc is a cell analysis solutions company advancing the next generation of cell analysis tools by leveraging novel technical approaches. Its core instruments, the Cytek Aurora and Northern Lights systems, are the first full-spectrum flow cytometers able to deliver high-resolution, high-content, and high-sensitivity cell analysis by utilizing the full spectrum of fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells. Its FSP platform addresses the inherent limitations of other technologies by providing a higher density of information with greater sensitivity, more flexibility, and increased efficiency, all at a lower cost for performance. Geographically, the company generates a majority of its revenue from the United States.
See More
Previous Close:
$4.13
Open:
$4.12
24h Volume:
974.07K
Relative Volume:
0.89
Market Cap:
$501.26M
Revenue:
$193.01M
Net Income/Loss:
$-12.15M
P/E Ratio:
-43.78
EPS:
-0.09
Net Cash Flow:
$454.00K
1W Performance:
-1.99%
1M Performance:
-2.23%
6M Performance:
-5.52%
1Y Performance:
-16.88%
1-Day Range:
$3.93
$4.12
1-Week Range:
$3.72
$4.205
52-Week Range:
$2.37
$7.63
Cytek Biosciences Inc Stock (CTKB) Company Profile
Name
Cytek Biosciences Inc
Sector
Industry
Phone
(877) 922-9835
Address
47215 LAKEVIEW BOULEVARD, FREMONT
Compare CTKB with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CTKB
Cytek Biosciences Inc
|
3.94 | 475.82M | 193.01M | -12.15M | 454.00K | -0.09 |
|
ABT
Abbott Laboratories
|
133.73 | 225.15B | 43.11B | 13.94B | 6.78B | 7.98 |
|
BSX
Boston Scientific Corp
|
102.71 | 155.92B | 18.49B | 2.50B | 3.49B | 1.68 |
|
SYK
Stryker Corp
|
383.34 | 146.41B | 23.82B | 2.92B | 4.02B | 7.55 |
|
MDT
Medtronic Plc
|
94.03 | 118.42B | 34.20B | 4.69B | 5.30B | 3.63 |
|
EW
Edwards Lifesciences Corp
|
77.57 | 45.96B | 5.69B | 1.41B | 577.90M | 6.95 |
Cytek Biosciences Inc Stock (CTKB) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| May-09-25 | Downgrade | TD Cowen | Buy → Hold |
| Jan-31-25 | Downgrade | Goldman | Buy → Sell |
| Dec-14-23 | Initiated | Stephens | Overweight |
| Jul-19-23 | Initiated | Raymond James | Mkt Perform |
| Jan-06-22 | Resumed | Piper Sandler | Overweight |
Cytek Biosciences Inc Stock (CTKB) Latest News
Will earnings trigger a reversal in Cytek Biosciences Inc.July 2025 Short Interest & AI Enhanced Trade Execution Alerts - Newser
Will Cytek Biosciences Inc. outperform the market2025 Market Sentiment & Stepwise Entry and Exit Trade Signals - Newser
Does Cytek Biosciences Inc. show high probability of rebound2025 Earnings Surprises & Low Drawdown Investment Strategies - Newser
What earnings revisions data tells us about Cytek Biosciences Inc.2025 Trading Recap & AI Enhanced Trading Signals - Newser
Cytek Biosciences Inc. stock daily chart insights2025 Volatility Report & Weekly Consistent Profit Watchlists - Newser
How moving averages guide Cytek Biosciences Inc. tradingMarket Sentiment Summary & Daily Chart Pattern Signal Reports - Newser
Historical volatility pattern of Cytek Biosciences Inc. visualizedQuarterly Market Review & Real-Time Stock Price Movement Reports - Newser
How sentiment analysis helps forecast Cytek Biosciences Inc.July 2025 Breakouts & Expert Verified Stock Movement Alerts - Newser
Jacobs Levy Equity Management Inc. Takes $2.84 Million Position in Cytek Biosciences, Inc. $CTKB - MarketBeat
Cytek Biosciences Inc. stock volume spike explainedOil Prices & Target Return Focused Stock Picks - Newser
Using R and stats models for Cytek Biosciences Inc. forecasting2025 Stock Rankings & Daily Stock Momentum Reports - Newser
Is Cytek Biosciences Inc. reversing from oversold territoryStop Loss & Daily Profit Maximizing Tips - Newser
Will Cytek Biosciences Inc. rebound enough to break evenTake Profit & Verified Swing Trading Watchlist - Newser
Cytek Biosciences Inc. stock prediction for this weekQuarterly Performance Summary & Risk Managed Trade Strategies - Newser
Trexquant Investment LP Has $2.20 Million Holdings in Cytek Biosciences, Inc. $CTKB - MarketBeat
Cytek Biosciences Brings Full Spectrum Cell Analysis to Leading Clinical Global Conferences ICCS and ESCCA - GlobeNewswire
Cytek Biosciences Brings Full Spectrum Cell Analysis to Leading Clinical Global Conferences Iccs and Escca - MarketScreener
PDT Partners LLC Takes Position in Cytek Biosciences, Inc. $CTKB - MarketBeat
Regression analysis insights on Cytek Biosciences Inc. performanceJuly 2025 Recap & Safe Capital Investment Plans - Newser
Key metrics from Cytek Biosciences Inc.’s quarterly dataJuly 2025 Big Picture & Weekly Top Gainers Alerts - Newser
What to do if you’re stuck in Cytek Biosciences Inc.Earnings Risk Summary & Community Consensus Picks - Newser
Technical signs of recovery in Cytek Biosciences Inc.2025 Big Picture & Daily Stock Trend Watchlist - Newser
Is it too late to sell Cytek Biosciences Inc.July 2025 Macro Moves & Entry and Exit Point Strategies - Newser
How to build a custom watchlist for Cytek Biosciences Inc.July 2025 Opening Moves & Community Verified Watchlist Alerts - Newser
What’s the recovery path for long term holders of Cytek Biosciences Inc.July 2025 Closing Moves & AI Forecasted Stock Moves - Newser
Is Cytek Biosciences Inc. meeting your algorithmic filter criteriaJuly 2025 Institutional & Expert Approved Trade Ideas - Newser
Sentiment Review: Does Cytek Biosciences Inc. stock benefit from AI growthTrade Analysis Report & Low Volatility Stock Recommendations - Lancaster City Council
Cytek Biosciences: Growth Over Profit Will Pay Off In The Long Term (NASDAQ:CTKB) - Seeking Alpha
How to build a dashboard for Cytek Biosciences Inc. stockWeekly Stock Analysis & Community Verified Trade Signals - Newser
Is Cytek Biosciences Inc. showing signs of accumulationWeekly Risk Report & Reliable Volume Spike Alerts - Newser
using r and stats models for cytek biosciences inc. forecastingBond Market & Long Hold Capital Preservation Tips - Newser
Panagora Asset Management Inc. Raises Position in Cytek Biosciences, Inc. $CTKB - MarketBeat
analyzing recovery setups for cytek biosciences inc. investorsJuly 2025 Opening Moves & Community Consensus Stock Picks - Newser
Fibonacci Retracement Aligns with Support in Cytek Biosciences Inc.2025 Institutional Moves & Real-Time Volume Analysis Alerts - beatles.ru
Trendlines Converge — Decision Point for Cytek Biosciences Inc.Weekly Stock Analysis & Low Volatility Stock Suggestions - beatles.ru
Identifying reversal signals in Cytek Biosciences Inc.Index Update & Low Drawdown Trading Techniques - Newser
Cytek Biosciences Inc Stock (CTKB) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.14%
1.01%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):